InsidersTradesSigma
Cell Impact AB (publ): directors' dealings · Finland · FIN-FSA
FI:cell-impact-ab-publSE0025159528FI·FIN-FSAMcap 77M€Industrials
Explore the full management transaction log of Cell Impact AB (publ), a publicly traded company based in Finland. Shares are listed on FI FI, under the supervision of FIN-FSA. Operating in the Industrials sector, Cell Impact AB (publ) has published 9 public disclosures. Market capitalisation: €76.7m. The latest transaction was reported on 2 March 2026 (Purchase). Among the most active insiders: Mats Boqvist. All data is accessible without an account.
9
Insider Decl.
0
Thresholds
€102,767
9 ops.
Buy Volume
·
0 ops.
Sell Volume
Financial data
FY ended December 2025 · cache
0.16 €
Analyst consensus
Income statement
Revenue5.6 M€
Gross profit−5.1 M€-91% margin
Net income−132.0 M€-2369.6% margin
Valuation
P/Book0.5x
Balance sheet & cash
Market cap76.7 M€
Total debt26.6 M€
Free Cash Flow−47.3 M€
Debt / Equity12%
Profitability & ownership
ROE-80.7%
ROA-40.0%
% insiders7.5%
% institutions1.5%
Last declaration on 2 March 2026
Declarations9 total
Executives●Purchase18FIN-FSA
€9,755800,000 shares@ €0.01220.013% mcap13.5% of flow
BTA (betald tecknad aktie)
FI:A003W625-1·
Ideal exit: 23 Nov 2026 (T+270)
Executives●Purchase13FIN-FSA
€3,346275,000 shares@ €0.01220.0044% mcap45.3% of flow
BTA (betald tecknad aktie)
FI:A003W363-1·
Ideal exit: 17 Nov 2026 (T+270)
Executives●Purchase16FIN-FSA
€1,840151,250 shares@ €0.01220.0024% mcap100.0% of flow
BTA (betald tecknad aktie)
FI:A003W356-1·
Ideal exit: 17 Nov 2026 (T+270)
Executives●Purchase23FIN-FSA
€26,7662,200,000 shares@ €0.01220.035% mcap37.1% of flow
BTA (betald tecknad aktie)
FI:A003W355-1·
Ideal exit: 17 Nov 2026 (T+270)
Executives●Purchase19FIN-FSA
€15,3111,000,000 shares@ €0.01530.020% mcap100.0% of flow
Aktie
FI:A003R854-1·
Ideal exit: 24 May 2026 (T+270)
Executives●Purchase14FIN-FSA
€19,49611,000,000 shares@ €0.00180.025% mcap27.0% of flow
Teckningsrätt/Uniträtt
FI:A003Q680-1·
Ideal exit: 11 Apr 2026 (T+270)
Executives●Purchase13FIN-FSA
€16,1859,000,000 shares@ €0.00180.021% mcap22.4% of flow
Teckningsrätt/Uniträtt
FI:A003Q556-2·
Ideal exit: 6 Apr 2026 (T+270)
Executives●Purchase13FIN-FSA
€4,0462,250,000 shares@ €0.00180.0053% mcap54.7% of flow
BTA (betald tecknad aktie)
FI:A003Q589-1·
Ideal exit: 6 Apr 2026 (T+270)
Executives●Purchase32FIN-FSA
€6,0233,349,008 shares@ €0.00180.0079% mcap100.0% of flow
BTA (betald tecknad aktie)
FI:A003Q585-1·
Ideal exit: 6 Apr 2026 (T+270)
9 of 9 declarations